Rola homocysteiny w powstawaniu miażdżycy

• Autorzy: Szostak-Wegierek D.

Warianty tytułu

EN

The role of homocysteine in atherogenesis

• Języki publikacji: PL
• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 1991
• Tom: 18
• Numer: 2
• Opis fizyczny: s.132-142,rys.,bibliogr.

Twórcy

autor

Szostak-Wegierek D.

• Zakład Szkolenia i Oświaty Zdrowotnej, Instytut Żywności i Żywienia w Warszawie, Warszawa

Bibliografia

• 1.Boers G. H. J.: Homocystinuria, a risk factor of premature vascular disease. Dordrecht, Foris, 1986.
• 2. Boers G. H. J.: Carriership of homocystinuria in juvenile vascular disease. Haemostasis 1989, 19 (Suppl), 29.
• 3. Boers G. H. J., Smals A. G.H., Trijbels F. J. M., et al.: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med., 1985, 313, 709.
• 4. Boers G. H. J., Smals A. G. H., Trijbels F. J. M„ et al.: Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J. Clin. Invest., 1983, 72, 1971.
• 5. Brattstrom L., Israelsson B., Norrving B., et al.: Impaired homocysteine metabolism in early-onset cerebral and peripheral treatment. Atherosclerosis 1990, 81, 51.
• 6. David E. L., Dudman P. B. D.: Mechanism of thrombogenesis and accelerated atherogenesis H., Suzuki L. A., et al.: The role of sulfur containing amino acids in superoxide Production and modification ow low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem., 1987, 262, 10098.
• 8. Israelsson B., Brattstrom B., Hultberg B. J.: Homocysteine and myocardial infarction. Atherosclerosis 1988, 71, 227.
• 9. Kang S. S., Wong P. W. K., Becker N.: Protein-bound homocyst(e)ine in normal subjects and in patients with homocystinuria. Pediat. Res., 1979, 13, 1141.
• 10. Kang S. S., Wong P. W. K., Cook H. Y., et al.: Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J. Clin. Invest., 1986, 77, 1482.
• 11.Malinow M.R., Kang S.S., Taylor L.M., et al.: Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989, 79, 1180.
• 12. Mc Cully K. S.: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Amer. J. Pathol., 1969, 56, 111.
• 13. Mc Cully K. S.: Homocysteine theory of arteriosclerosis development and current status. Atheros. Rev., 1983, 11, 157.
• 14. Mc Cully K.S.: Atherosclerosis, serum cholesterol and the homocysteine theory: a study of consecutive autopsies. Amer. J. Med. Sci., 1990, 299, 217.
• 15. Mc Cully K. S., Carvalho A. C. A.: Homocysteine thiolactone, N-homocysteine thiolactonyl retinamide, and platelet aggregation. Res. Commun. Chem. Pathol. Pharm., 1987, 56, 349.
• 16. Mc Cully K. S., Ragsdale B. D.: Production of arteriosclerosis by homocysteinemia. Amer. J. Pathol., 1970, 61, 1.
• 17. Me Cully K. S., Wilson R. B.: Homocysteine theory of arteriosclerosis. Atherosclerosis 1975, 22, 215.
• 18. Mohammed R., Lamand M.: Cardiovascular lessions in cobalt-vitamin B12 deficient sheep. Ann. Rech. Vet., 1986, 17, 447.
• 19. Mudd S. H., Finkelstein J. D., Irreverre F., et al.: Homocystinuria: an enzymatic defect. Science 1964, 143, 1443.
• 20. Mudd S. H., Levy H. L.: Disorders of transsulfuration. In: Metabolic basis of inherited disease. Ed: J. B. Standbury. New York, Me Graw-Hill Publications, 1983, 522.
• 21. Mudd S. H., Poole J. R.: Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975, 24, 721.
• 22. Mudd S., Scovby F., Levy H. L., et al.: The natural history of homocystinuria due to cystathionine /j-sythase deficiency. Amer. J. Hum. Genet., 1985, 37, 1.
• 23. Mudd S. H., Uhlendorf B. W., Freeman J. M., et al.: Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem. Biohys. Res. Commun., 1972, 46, 905.
• 24. Olszewski A. J.: Homocysteinowa teoria miażdżycy. Pol. Arch. Med. Wew., 1987, 77, 53.
• 25. Olszewski A. J., Mc Cully K. S., Szostak W. B.: Homocysteine content of lipoproteins in hypercholesterolemia. Atherosclerosis (in press).
• 26. Olszewski A. J., Ryć M., Szostak W. B.: Teoretyczne mozliwosci profilaktyki miażdżcy w oparciu o homocysteinową teorię aterogenezy. 2yw. Czlow. Metab., 1988, 15, 211.
• 27. Olszewski A.J., Szostak W.B.: Homocysteine content of plasma proteins in ischemic heart disease. Atherosclerosis 1988, 69, 109.
• 28. Olszewski A. J., Szostak W. B., Bialkowska M., et al.: Reduction of plasma lipid and homocysteine levels by pyridoxne, folate, cobalamin, choline, riboflavin and troxerutin in atherosclerosis. Atherosclerosis 1989, 71, 1.
• 29. Olszewski A.J., Szostak W.B., McCully K. S.: Plasma glucosamine and galactosamine in ischemic heart disease. Atherosclerosis 1990, 82, 75.
• 30. Parthasarathy S.: Oxidation of low density lipoprotein by thiol compounds leads to its recogniton by the acetyl LDL receptor. Biochim. Biophys. Acta 1987, 917, 337.
• 31. Rinehart J. F., Greenberg L. D.: Arteriosclerotic lesions in pyridoxine-deficient monkeys. Amer. J. Pathol., 1949, 25, 481.
• 32. Skovby F.: Homocystinuria. Clinical, biochemical and genetic aspects of cystathionine /l-syntethase and its deficiency in man. Acta Paediatr. Scand., 1985, 321, 1.
• 33. Smolin L. A., Benevenga N. J., Berlow S.: The use of betaine for the treatment of homocystynuria. J. Pediatr., 1981, 99, 467.
• 34. Smolin L. A., Crenshaw T. D., Kurtycz D., et al.: Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B6: relationship to atheroscle rosis. J. Nutr., 1983, 113, 222.
• 35. Swift M., Morrell D.: Cardiovascular risk in homocystinuria family members. Amer. J. Hum. Genet., 1982, 34, 1016.
• 36. Ueland P. M.: Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev., 1982, 34, 223.
• 37. Ueland P. M., Refsum H.: Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med., 1989, 114, 473.
• 38. Berlow S.: The use of betaine for the treatment of homocystinuria. J. Pediatr., Vermaak W.H.J., Barnard H.C., Potgieter G.M., et al.: Vitamin B„ and coronary artery disease. Epidemiological observations and case studies. Atherosclerosis 1987, 63, 235.
• 39. Wilcken D. E. L., Dudman N. P. B., Tyrrel P. A.: Homocystinuria due to cysthationine /5-synthase deficiency — the effects of betaine treatment in pyridoxine-responsive patients. Clin. Exp., 1985, 34, 1115.
• 40. Wilcken D. E. L,, Gupta V. J.: Cysteine-homocysteine mixed disulfide: differing plasma concentrations in normal men and women. Clin. Sci., 1979, 57, 211.
• 41. Wilcken B., Turner G.: Homocystinuria in New South Wales. Arch. Dis. Child, 1978, 53, 242.

Uwagi

Rekord w opracowaniu